Brief: Bristol-Myers Squibb Will Be Required To Pay Karuna Therapeutics Fee Of $600 mln If Deal Terminated

Karuna Therapeutics

22/12/2023 22:19

Dec 22 (Reuters) - Bristol-Myers Squibb Co  BMY.N :
    * KARUNA THERAPEUTICS - IF DEAL TERMINATED, BRISTOL-MYERS
SQUIBB
WILL BE REQUIRED TO PAY CO TERMINATION FEE OF $600 MILLION UNDER
SOME CIRCUMSTANCES
    * KARUNA THERAPEUTICS: UPON TERMINATION OF DEAL UNDER
SPECIFIED
CIRCUMSTANCES, CO REQUIRED TO PAY BRISTOL-MYERS SQUIBB
TERMINATION FEE OF $490 MILLION

Further company coverage:  BMY.N 

 ((Reuters.Briefs@thomsonreuters.com;))